Illumina Corp (ILMN): Net earnings per share (EPS TTM)

Corporate company logo of Illumina Inc (ILMN)

Illumina, Inc. specializes in high-tech diagnostics. The 12-month net income per share snapshot demonstrates that the current status is 5.82. The company relies on the sale of unique DNA sequencers and consumables. A portion of production and cloud management has been outsourced to external partners. The business is currently undergoing a deep restructuring following the loss of a major asset, focusing on organic growth.

ILMN Illumina Platform Net earnings per share for the last four quarters (07/04/2022 - 11/17/2026)

Illumina Platform - analytical breakdowns and key metrics (ILMN)

- current quotes and average value forecast:
- stock exchange capitalization data:
Fundamental company valuation:illumina.com - ILMN
Mass-produced product of Illumina Corp

To distinguish a sustainable business from a speculative asset, it is necessary to analyze net income per share, which measures the security holder's actual annual income. Illumina, Inc. (ILMN) maintains monopoly control over the consumables market, and the inelastic demand for sequencing confirms the strength of these fundamentals, as reflected in the annual net income per share trend as a capitalization indicator.

Competitors of Illumina, Inc. (ILMN)

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|EXAS: Net earnings per share (EPS TTM)|RVTY - Net earnings per share for the last four quarters|BIO (Bio-Rad Laboratories) - Net earnings per share (EPS TTM)|Anbio Biotechnology (NNNN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Nordion (SHC)|QuidelOrtho Corp (QDEL) - Net earnings per share for the trailing year|Earnings per share for the last twelve months OPKO Health Inc OPK|Net earnings per share (EPS TTM) CareDx, Inc CDNA|MRVI - Earnings per share for the last twelve months|FLGT: Earnings per share for the last twelve months|LAB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc (CTKB)|Net earnings per share for the last 12 months OSUR|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months